Skip to main content Accessibility help
×
Home

Diagnosis of Inclusion

  • Kristin M. Ikeda (a1), Sumit Das (a2), Michael Strong (a1), Seyed M. Mirsattari (a1), Andrew Leung (a1) (a3), David Steven (a1) and Robert Hammond (a1) (a2)...
  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Diagnosis of Inclusion
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Diagnosis of Inclusion
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Diagnosis of Inclusion
      Available formats
      ×

Abstract

Copyright

Corresponding author

Correspondence to: Robert Hammond, Rm. A-148, Department of Pathology, LHSC-UH, 339 Windermere Road, London, ON N6A 5A5, Email: robert.hammond@lhsc.on.ca

References

Hide All
1. Brew, BJ, Davies, NW, Cinque, P, Clifford, DB, Nath, A. Progressive multifocal leukoencephalopathy and other forms of JC virus disease. Nat Rev Neurol. 2010;6:667-679.
2. Ferenczy, MW, Marshall, LJ, Nelson, CD, Atwood, WJ, Nath, A, Khalili, K, et al. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev. 2012;25:471-506.
3. Elphick, GF, Querbes, W, Jordan, JA, Gee, GV, Eash, S, Manley, K, et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science. 2004;306:1380-1383.
4. Gheuens, S, Wuthrich, C, Koralnik, IJ. Progressive multifocal leukoencephalopathy: why gray and white matter. Annu Rev Pathol. 2013;8:189-215.
5. Gheuens, S, Pierone, G, Peeters, P, Koralnik, IJ. Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression. J Neurol Neurosurg Psychiatry. 2010;81:247-254.
6. Delgado-Alvarado, M, Sedano, MJ, Gonzalez-Quintanilla, V, de Lucas, EM, Polo, JM, Berciano, J. Progressive multifocal leukoencephalopathy and idiopathic CD4 lymphocytopenia. J Neurol Sci.. 2013;327:75-79.
7. Berger, JR, Aksamit, AJ, Clifford, DB, Davis, L, Koralnik, IJ, Sejvar, JJ, et al. PML diagnostic criteria: consensus statement from the AAN neuroinfectious disease section. Neurology. 2013;80:1430-1438.
8. Tan, CS, Koralnik, IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol. 2010;9:425-437.
9. Marzocchetti, A, Tompkins, T, Clifford, DB, Gandhi, RT, Kesari, S, Berger, JR, et al. Determinants of survival in progressive multifocal leukoencephalopathy. Neurology. 2009;73:1551-1558.
10. Clifford, DB, Nath, A, Cinque, P, Brew, BJ, Zivadinov, R, Gorelik, L, et al. A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes. J Neurovirol. 2013;19:351-358.
11. Hall, CD, Dafni, U, Simpson, D, Clifford, D, Wetherill, PE, Cohen, B, et al. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS clinical trials group 243 team. N Engl J Med. 1998;338:1345-1351.
12. Marra, CM, Rajicic, N, Barker, DE, Cohen, BA, Clifford, D, Donovan Post, MJ, et al. A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. AIDS. 2002;16:1791-1797.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed